US2005288348A1PendingUtilityA1
Compounds and methods for use thereof in the treatment of cancer
Assignee: UAF TECHNOLOGIES AND RES LLCPriority: Sep 26, 2000Filed: Aug 16, 2005Published: Dec 29, 2005
Est. expirySep 26, 2020(expired)· nominal 20-yr term from priority
C07D 235/32A61K 31/4184C07D 235/30
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
Claims
exact text as granted — not AI-modified1 . A method for treating cancer susceptible to treatment in a warm-blooded animal comprising administering to the warm-blooded animal a therapeutically effective amount of a compound of the following formula:
wherein,
R is —COOR 2 or —CONHR 2 ;
R 2 is alkyl, haloalkyl, alkenyl, haloalkenyl, cycloalkyl, cycloalkalkyl, heterocycloalkyl, heterocycloalkalkyl, substituted or unsubstituted benzyl, hydroxyalkyl, alkoxyalkyl, poly(alkoxy)alkyl, hydroxyalkoxyalkyl, hydroxypoly(alkoxy)alkyl, haloalkoxyalkyl, halopoly(alkoxy)alkyl, or aminoalkyl; and
each of X and Y is independently hydrogen, alkyl, alkenyl, cycloalkyl, haloalkyl, haloalkenyl, halogen, nitro, or amino;
wherein the compound is in the form of a liposome delivery system.
2 . The method of claim 1 wherein the liposome delivery system is in the form of multilamellar vesicles.
3 . The method of claim 1 wherein the liposome delivery system is in the form of unilamellar vesicles.
4 . A method according to claim 1 wherein said compound is of the following formula A-1:
5 . A method according to claim 4 wherein R 2 is selected from the group consisting of alkyl, haloalkyl, alkenyl, and substituted or unsubstituted benzyl.
6 . A method according to claim 1 wherein said compound is of the following formula A-2:
7 . A method according to claim 6 wherein R 2 is selected from the group consisting of alkyl, haloalkyl, and substituted or unsubstituted benzyl.
8 . A method for treating cancer susceptible to treatment in a warm-blooded animal comprising administering to the warm-blooded animal a therapeutically effective amount of a compound of the following formula:
wherein,
R is —COOR 2 or —CONHR 2 ;
R 2 is heterocycloalkyl or heterocycloalkalkyl; and
each of X and Y is independently hydrogen, alkyl, alkenyl, cycloalkyl, haloalkyl, haloalkenyl, halogen, nitro, or amino.
9 . A method according to claim 8 wherein said compound is of the following formula A-1:
10 . A method according to claim 8 wherein said compound is of the following formula A-2:
11 . A method according to claim 8 wherein said compound is in the form of a pharmaceutically acceptable salt thereof.
12 . A method according to claim 8 wherein said cancer is a carcinoma.
13 . A method according to claim 8 wherein said cancer is leukemia.
14 . A method according to claim 8 wherein said cancer is melanoma.
15 . A method according to claim 8 wherein said cancer is colon cancer.
16 . A method according to claim 8 wherein said cancer is breast cancer.
17 . A method according to claim 8 wherein said cancer is lung cancer.
18 . A method according to claim 8 wherein said cancer is pancreatic cancer.
19 . A method according to claim 8 wherein said cancer is ovarian cancer.
20 . A method according to claim 8 wherein said cancer is prostate cancer.Join the waitlist — get patent alerts
Track US2005288348A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.